Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg or 50 mg once daily over 4 weeks, then in the long-term flexible doses 15-50mg daily over a period of 52 weeks.
Sponsor: Reviva Pharmaceuticals
Check if you qualify for this schizophrenia clinical trial in Phoenix, AZ
If you're searching for schizophrenia treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.